PA
AGN

Procyon Advisors’s Allergan plc AGN Stock Holding History

Procyon Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed -$1K – 1238
2020
Q1 		$1K Hold
5
– – ﹤0.01% 983
2019
Q4 		$1K Buy
+5
New +$902 ﹤0.01% 981

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Procyon Advisors's AGN Position: Q2 2020 in Review

Procyon Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5 shares — an estimated $1K sold.

Procyon Advisors first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Procyon Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Procyon Advisors sold 5 Allergan plc shares in Q2 2020, an estimated $1K.
  • Procyon Advisors first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Procyon Advisors's Allergan plc position peaked at $1K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Procyon Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.